Moving from lab to large scale builds upon all the competencies required for handling HPAPIs. Particular attention must be paid to safe handling, containment systems, to protect workers from exposure and cross-contamination prevention.
In the third webinar of our series, we invite you to take a closer look at Evonik’s large-scale production site in Lafayette, Indiana located in the U.S. Your guides Ben Larson, Theresa Ledbetter, and Robert Farner will talk you through the many considerations needed to handle a multi-ton HPAPI production. You will get insights into challenges and lessons learned which have helped build a successful HPAPI CDMO business.
This webinar is suitable for anyone in external manufacturing outsourcing, procurement, engineering, EHS, industrial hygiene, quality assurance, or project management, who is interested in learning more about large scale HPAPI manufacturing.Key learnings for participants of this webinar:
- The hidden risks of handling HPAPIs – items that may be overlooked or misunderstood
- Tips and tricks for successful highly potent API manufacturing
- Real-life examples, photos and case studies
Related webinars in this series
This is the third and last webinar of our 3-part webinar series entitled "Handling HPAPIs: From toxicological risk assessment to metric ton manufacturing". Join us to follow the journey of a highly potent molecule, starting from toxicological assessment to initial tech transfer and development onto large scale (metric ton) commercial manufacture.
To learn more about the two other webinars in this series please click on the respective webinar below. To register for multiple webinars of this series simply select them in the registration form.